维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Erben N"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The prevalence of exlended - spectrum beta - latamaze - producing Escherohia eoli and Klebsiella pneumoniae in clinical isolates and risk factors 显示文摘	Qzx/unes I Erben N Kiremitci A	2006	Scan Med J2006，27，5：	1
2	The prevalence of extended-spectrum beta-latamase-producing Escherchia coli and Klebsiella pneumoniae in clinical isolates and risk factors显示文摘	Qzqunes I Erben N Kiremitci A		0，，05：	1
3	International Nosocomial Infection Control Consortium(INICC)national report on device-associated infection rates in 19cities of Turkey,data summary for 2003-2012显示文摘	Leblebicioglu H Erben N Rosenthal VD	2014	Ann Clin Microbiol Antimicrob2014，，13：	1
4	Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents 显示文摘	Erben N Alpat SN Kartal ED	2009	Mikrobiyol Bul2009，43，1：	1
5	In vitro activity of ertapenem and other carbapenems against extended -spectrum beta- lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey 显示文摘	Kiremitci A Dinleyici EC Erben N	2008	Expert Opin Pharmacother2008，9，9：	1
6	Brueenosis : a retrospeetive evaluation of 99 eases and review of brucellnsis treatment 显示文摘	Demirttirk Demirdal T Erben N	2008	Trop Doct2008，38，1：	1
7	The prevalence of extended-spectrum beta-latamase-producing Escherchia coli and Klebsiella pneumoniae in clinical isolates and risk factors显示文摘	Ozgunes I Erben N Kiremitci A	2006	Saudi Med J2006，27，5：	1
8	The prevalence of extended-spectrum beta-latamase-producing Escherchia coli and Klebsiella pneumoniae in clinical isolates and risk factors 显示文摘	Qzqunes I Erben N Kiremitci A	2006	Scan Med J2006，27，5：	1
9	In vitro activity of ertapenem and other carbapenems against extended- spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey显示文摘	Kiremitci A Dinleyici EC Erben N	2008	Expert Opin Pharmacother2008，9，9：	1
10	Comparison of non-invasive fibro sis markers and classical liver biopsy in chronic hepatitis C 显示文摘	Usluer G Erben N Aykin N	2012	Eur J Clin Microbiol Infect Dis2012，31，8：	1
11	Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative a- gents显示文摘	Erben N Alpat SN KartaI ED	2009	Mikrobiyol Bui2009，43，1：	1
12	The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors显示文摘	Erben N Kiremitci A	2006	Saudi Med J2006，27，5：	1
13	The prev-alence of extended-spectrum-beta-latamase-produ-cing Escherchia coli and Klebsiella pneumoniae inclinical isolates and risk factors 显示文摘	Ozgunes I Erben N Kiremitci A	2006	Saudi Med2006，27，5：	1
14	In vitro activity of ertapenem and other carbapenems against extend-ed-spectrum beta-laetamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey显示文摘	Kiremitci A Dinleyici EC Erben N	2008	Expert Opin Pharmacother2008，9，9：	1
15	The prevalence of extended-spectrum beta-latamase-producing Escherchia coli and Klebsiellapneumoniae in clinical isolates and risk factors显示文摘	Qzqunes I Erben N Kiremitci A et a1	2006	Scan Med J2006，27，5：	1
16	Brucellosis: a retrospective evalu- ation of 99 eases and review of brucellosis treatment显示文摘	Demirttlurk N Demirdal T Erben N	2008	Tropical Doe- tor2008，138，：	1
17	In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Eschericlaia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey显示文摘	Kiremitci A Dinleyici EC Erben N	2008	Expert Opin Pharmacother2008，9，9：	1
18	The prevalence of extended-spectrum beta-latamase-producing Escherchia coli and Klebsiella pneumoniae in clinical isolates and risk factors显示文摘	Ozgunes I Erben N Kiremitci A	2006	Saudi Med J2006，27，5：	1
19	The prevalence of extended spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors显示文摘	Ozqunes I Erben N Kiremitci A	2006	Saudi Med J2006，27，5：	1
20	In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey 显示文摘	Kiremitci A Dinleyici EC Erben N	2008	Expert Opin Pharmacother2008，9，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示